Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etrolizumab induction and maintenance in moderate to severe Crohn's disease
NL-OMON47704Phase 3Active, not recruiting
- Sponsor
- Roche
- Start
- Dec 2015
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3 trial of Etrolizumab, sponsored by Roche. Started Dec 2015; status: active, not recruiting.
02
Drugs
Etrolizumab
Beyond the preview
Go deeper on NL-OMON47704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47704.